Benign Prostatic Hyperplasia – Prostate Cancer – Prostatitis

Chlorotrianisene

No Comments

Drug Approvals

(British Approved Name, rINN)

International Nonproprietary Names (INNs) in main languages (French, Latin, and Spanish):

Synonyms: Chlorotrianisenum; Clorotrianiseno; Klooritrianiseeni; Klortrianisen; NSC-10108; Tri-p-anisylchloroethylene
BAN: Chlorotrianisene
INN: Chlorotrianisene [rINN (en)]
INN: Clorotrianiseno [rINN (es)]
INN: Chlorotrianisène [rINN (fr)]
INN: Chlorotrianisenum [rINN (la)]
INN: Хлоротрианизен [rINN (ru)]
Chemical name: Chlorotris(4-methoxyphenyl)ethylene
Molecular formula: C23H21ClO3 =380.9
CAS: 569-57-3
ATC code: G03CA06

Pharmacopoeias. In China.

Profile

Chlorotrianisene is a synthetic nonsteroidal oestrogen structurally related to diethylstilbestrol. It has a prolonged action, and has been given orally for the treatment of menopausal symptoms, female hypogonadism, and prostatic carcinoma.

Single-ingredient Preparations

The symbol ¤ denotes a preparation which is discontinued or no longer actively marketed

Belgium: Tace¤; Canada: Tace¤; France: Tace¤; Germany: Merbentul¤; Mexico: Estregur¤; Spain: Tace¤; Switzerland: Tace¤; United States: Tace¤

 
Posted in: Drugs

Leave a Reply

You must be logged in to post a comment.